These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29372844)

  • 41. Comparison of two 22 G aspiration needles for histologic sampling during endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA).
    Izumo T; Sasada S; Watanabe J; Chavez C; Matsumoto Y; Tsuchida T
    Jpn J Clin Oncol; 2014 Sep; 44(9):841-5. PubMed ID: 25057090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adequacy of core needle biopsy specimens and fine-needle aspirates for molecular testing of lung adenocarcinomas.
    Schneider F; Smith MA; Lane MC; Pantanowitz L; Dacic S; Ohori NP
    Am J Clin Pathol; 2015 Feb; 143(2):193-200; quiz 306. PubMed ID: 25596245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictive markers in lung cancer: a few hints for the practicing pathologist.
    Barbareschi M; Barberis M; Buttitta F; Doglioni C; Fiorentino M; Fontanini G; Franco R; Marchetti A; Rossi G; Troncone G
    Pathologica; 2018 Mar; 110(1):29-38. PubMed ID: 30259911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endobronchial ultrasound-guided transbronchial needle aspiration of hilar and mediastinal lymph nodes detected on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Minami D; Takigawa N; Oda N; Ninomiya T; Kubo T; Ohashi K; Sato A; Hotta K; Tabata M; Kaji M; Tanimoto M; Kiura K
    Jpn J Clin Oncol; 2016 Jun; 46(6):529-33. PubMed ID: 27004902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Value of cytopathology in endobronchial ultrasound-guided transbronchial needle aspiration].
    Chen Y; Ping B; Wang LF; Feng LQ; Xu WP; Wu JW; Yang WT; Zhou XY; Cai X; Hu H; Chen HQ; Shen L
    Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):44-7. PubMed ID: 22455850
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of a Dual ALK/ROS1 Fluorescent In Situ Hybridization Test in Non-Small-cell Lung Cancer.
    Ginestet F; Lambros L; Le Flahec G; Marcorelles P; Uguen A
    Clin Lung Cancer; 2018 Sep; 19(5):e647-e653. PubMed ID: 29801706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.
    Li W; Zhang Z; Guo L; Qiu T; Ling Y; Cao J; Guo H; Zhao H; Li L; Ying J
    Oncotarget; 2016 Feb; 7(7):8332-40. PubMed ID: 26789109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Somatic mutations and immune checkpoint biomarkers.
    Parris BA; Shaw E; Pang B; Soong R; Fong K; Soo RA
    Respirology; 2019 Mar; 24(3):215-226. PubMed ID: 30636374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Identification of an optimal algorithm for effective diagnostics of non-small cell lung cancer with ALK gene rearrangement - implementation of the method and practical experiences with routine diagnostics].
    Rozkoš T; Ryška A; Nová M; Hornychová H; Krbal L; Matěj R; Laco J
    Cesk Patol; 2017; 53(2):89-96. PubMed ID: 28597670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.
    Cai G; Wong R; Chhieng D; Levy GH; Gettinger SN; Herbst RS; Puchalski JT; Homer RJ; Hui P
    Cancer Cytopathol; 2013 Sep; 121(9):500-7. PubMed ID: 23495083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Preparation Technique on Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Sample Adequacy: 3 Years of Experience from a Single Center.
    Ece D; Geçmen G; Kökten Ş; Cömert SŞ
    Turk Patoloji Derg; 2019; 35(3):198-206. PubMed ID: 30859517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preanalytic parameters in epidermal growth factor receptor mutation testing for non-small cell lung carcinoma: A review of cytologic series.
    da Cunha Santos G; Saieg MA
    Cancer Cytopathol; 2015 Nov; 123(11):633-43. PubMed ID: 26288231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The value of ultrasound-guided biopsy of fluorodeoxy-glucose positron emission tomography (FDG-PET)-positive supraclavicular lymph nodes in patients with suspected lung cancer.
    Werner L; Keller FA; Bhure U; Roos JE; Tornquist K; Del Sol Pèrez-Lago M; Gautschi O; Strobel K
    BMC Med Imaging; 2017 Jul; 17(1):41. PubMed ID: 28693444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytology samples and molecular biomarker testing in lung cancer-advantages and challenges.
    Canberk S; Engels M
    Virchows Arch; 2021 Jan; 478(1):45-57. PubMed ID: 33389149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment.
    Proietti A; Alì G; Pelliccioni S; Lupi C; Sensi E; Boldrini L; Servadio A; Chella A; Ribechini A; Cappuzzo F; Miccoli M; Fontanini G
    Cancer Cytopathol; 2014 Jun; 122(6):445-53. PubMed ID: 24648382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluorescence in Situ Hybridization (FISH) for Detecting Anaplastic Lymphoma Kinase (
    Tang Z; Wang L; Tang G; Medeiros LJ
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412611
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterations.
    Lou NN; Zhang XC; Chen HJ; Zhou Q; Yan LX; Xie Z; Su J; Chen ZH; Tu HY; Yan HH; Wang Z; Xu CR; Jiang BY; Wang BC; Bai XY; Zhong WZ; Wu YL; Yang JJ
    Oncotarget; 2016 Oct; 7(40):65185-65195. PubMed ID: 27533086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [National variation in molecular diagnostics in metastatic lung cancer].
    Kuijpers CCHJ; van den Heuvel MM; Overbeek LIH; van Slooten HJ; van Lindert ASR; Damhuis RAM; Willems SM
    Ned Tijdschr Geneeskd; 2018 Dec; 162():. PubMed ID: 30570921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improving Adequacy of Small Biopsy and Fine-Needle Aspiration Specimens for Molecular Testing by Next-Generation Sequencing in Patients With Lung Cancer: A Quality Improvement Study at Dartmouth-Hitchcock Medical Center.
    Padmanabhan V; Steinmetz HB; Rizzo EJ; Erskine AJ; Fairbank TL; de Abreu FB; Tsongalis GJ; Tafe LJ
    Arch Pathol Lab Med; 2017 Mar; 141(3):402-409. PubMed ID: 27763790
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue acquisition and specimen processing in the diagnosis of NSCLC.
    Akulian J; Yarmus L; Feller-Kopman D
    Semin Respir Crit Care Med; 2013 Dec; 34(6):787-91. PubMed ID: 24258568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.